Topic Review
Pharmacists and Medication Regimen Complexity
Medication regimen complexity (MRC) may influence health outcomes, such as hospitalisation, hospital readmission and medication adherence. Pharmacists have been referred to as health professionals with the opportunity to act on MRC reduction.
  • 349
  • 31 Aug 2021
Topic Review
Mentha piperita
Mentha species are famous as therapeutic herbs and have long served as natural herbal formulations. Mentha piperita L. (peppermint) is regarded as one of the best potential sources of biologically active substances for the food, cosmetics, and pharmaceutical industries. M. piperita, a hybrid mint, is a cross-species between watermint (Mentha aquatica L.) and spearmint (Mentha spicata L.). Other Mentha species are also cultivated around the world for essential oil production.
  • 349
  • 27 Nov 2023
Topic Review
Bioplastic-Based Nanoparticles for Drug Delivery Systems
Plastics have changed human lives, finding a broad range of applications from packaging to medical devices. Biodegradable plastic materials have been introduced on the market. These polymers are biodegradable but also bioresorbable and, indeed, are fundamental tools for drug formulations, thanks to their transient ability to pass through biological barriers and concentrate in specific tissues.
  • 348
  • 01 Nov 2023
Topic Review
Extracellular Vesicles-Loaded Microneedle Technology
Microneedles (MNs), renowned for their painless and minimally invasive qualities, exhibit significant potential for facilitating effective drug delivery, vaccination, and targeted sample extraction. Extracellular vesicles (EVs), serving as cargo for MNs, are naturally occurring nanovesicles secreted by cells and characterized by novel biomarkers, low immunogenicity, and cell-source-specific traits. MNs prove instrumental in extracting EVs from the sample fluid, thereby facilitating a promising diagnostic and prognostic tool. To harness the therapeutic potential of EVs in tissue repair, MNs with sustained delivery of EVs leverage micron-sized channels to enhance targeted site concentration, demonstrating efficacy in treating various diseases, such as Achillea tendinopathy, hair loss, spinal cord injury, and diabetic ulcers. EV-loaded MNs emerge as a promising platform for repair applications of skin, cardiac, tendon, hair, and spinal cord tissues.
  • 348
  • 18 Mar 2024
Topic Review
TRPA1 Role in Inflammatory Disorders
The transient receptor potential ankyrin 1 (TRPA1), a member of the TRP superfamily of channels, is primarily localized in a subpopulation of primary sensory neurons of the trigeminal, vagal, and dorsal root ganglia, where its activation mediates neurogenic inflammatory responses. The TRPA1 pathway could be a protective mechanism to detect and respond to harmful agents in various pathological conditions, including several inflammatory diseases.
  • 346
  • 09 May 2022
Topic Review
Disparities in Prevalence and Barriers to Hypertension Control
Controlling hypertension (HTN) remains a challenge, as it is affected by various factors in different settings. The prevalence of hypertension control in the low and middle-income countries and high-income countries studies ranged from (3.8% to 50.4%) to (36.3% to 69.6%), respectively. Concerning barriers to hypertension control, patient-related barriers were the most frequently reported, followed by medication adherence barriers, lifestyle-related barriers, barriers related to the affordability and accessibility of care, awareness-related barriers, and, finally, barriers related to prescribed pharmacotherapy.
  • 346
  • 09 Dec 2022
Topic Review
The Bioavailability of Drugs
Drug bioavailability is a crucial aspect of pharmacology, affecting the effectiveness of drug therapy. Understanding how drugs are absorbed, distributed, metabolized, and eliminated in patients’ bodies is essential to ensure proper and safe treatment. In addition to biochemical activity, bioavailability also plays a critical role in achieving the desired therapeutic effects. This may seem obvious, but it is worth noting that a drug can only produce the expected effect if the proper level of concentration can be achieved at the desired point in a patient’s body. Given the differences between patients, drug dosages, and administration forms, understanding and controlling bioavailability has become a priority in pharmacology. 
  • 346
  • 03 Jan 2024
Topic Review
Blood Biomarkers of Antipsychotic-Induced Metabolic Syndrome
A biomarker is a characteristic that is objectively measured and evaluated to detect disease in patients. Traditionally, laboratory diagnoses of Metabolic syndrome (MetS) and assessments of cardiovascular risk (CVR) include analyses of blood (serum or plasma) biomarkers, i.e., total cholesterol (TC), triglycerides (TG), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), insulin and C-peptide.
  • 345
  • 18 Aug 2022
Topic Review
Antibiotic Use and Resistance in Agriculture Sector
Possible new ways for the development of novel classes of antibiotics are discussed here, for which there is no pre-existing resistance in human bacterial pathogens. By utilizing research and technology such as nanotechnology and computational methods (such as in silico and Fragment-based drug design (FBDD)), there has been an improvement in antimicrobial actions and selectivity with target sites. Moreover, there are antibiotic alternatives, such as antimicrobial peptides, essential oils, anti-Quorum sensing agents, darobactins, vitamin B6, bacteriophages, odilorhabdins, 18β-glycyrrhetinic acid, and cannabinoids. Additionally, drug repurposing (such as with ticagrelor, mitomycin C, auranofin, pentamidine, and zidovudine) and synthesis of novel antibacterial agents (including lactones, piperidinol, sugar-based bactericides, isoxazole, carbazole, pyrimidine, and pyrazole derivatives) represent novel approaches to treating infectious diseases. Nonetheless, prodrugs (e.g., siderophores) have shown to be an excellent platform to design a new generation of antimicrobial agents with better efficacy against multidrug-resistant bacteria.
  • 345
  • 03 Apr 2023
Topic Review
Glutamate and GABA Dysfunction in Depression
Treatment-resistant depression (TRD) is a term used to describe a particular type of major depressive disorder (MDD). There is no consensus about what defines TRD, with various studies describing between 1 and 4 failures of antidepressant therapies, with or without electroconvulsive therapy (ECT). That is why TRD is such a growing concern among clinicians and researchers, and it explains the necessity for investigating novel therapeutic targets beyond conventional monoamine pathways. An imbalance between two primary central nervous system (CNS) neurotransmitters, L-glutamate and γ-aminobutyric acid (GABA), has emerged as having a key role in the pathophysiology of TRD.
  • 345
  • 15 Nov 2023
  • Page
  • of
  • 106
Video Production Service